학술논문
59 - Efficacy and safety of durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer: a single institution experience at University Hospital of North Midlands (UHNM) in the United Kingdom (UK)
Document Type
Abstract
Source
In Lung Cancer April 2023 178 Supplement 1:S25-S26
Subject
Language
ISSN
0169-5002